To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
Summary
What This Bill Does
The bill provides definitions In this Act: The term appropriate committees of Congress means— the Committee on the Judiciary of the Senate; and the Committee on the Judiciary of the House of Representatives. The term Commission, creates study of pharmaceutical supply chain intermediaries and merger activity, and provides report The Commission shall submit to the appropriate committees of Congress a report that includes— the number and nature of complaints received by the Commission relating to an allegation of anticompetitive. It relies on appropriations, reporting requirements, compliance mandates, and definition changes. The main policy areas are Regulated Industries, Healthcare, Education, and Housing.
Who Benefits and How
Patients and health care consumers affected by the bill could gain revenue opportunities, Researchers and scientific institutions affected by the bill could gain revenue opportunities, and Regulated entities and members of the public affected by the bill could gain revenue opportunities.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties.
Key Provisions
- Provides definitions In this Act: The term appropriate committees of Congress means— the Committee on the Judiciary of the Senate; and the Committee on the Judiciary of the House of Representatives. The term Commission...
- Creates study of pharmaceutical supply chain intermediaries and merger activity.
- Provides report The Commission shall submit to the appropriate committees of Congress a report that includes— the number and nature of complaints received by the Commission relating to an allegation of anticompetitive...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill provides definitions In this Act: The term appropriate committees of Congress means— the Committee on the Judiciary of the Senate; and the Committee on the Judiciary of the House of Representatives. The term Commission, creates study of pharmaceutical supply chain intermediaries and merger activity, and provides report The Commission shall submit to the appropriate committees of Congress a report that includes— the number and nature of complaints received by the Commission relating to an allegation of anticompetitive.
Key Policy Areas
Regulated Industries, Healthcare, Education, Housing
Primary Purpose
The bill provides definitions In this Act: The term appropriate committees of Congress means— the Committee on the Judiciary of the Senate; and the Committee on the Judiciary of the House of Representatives. The term Commission, creates study of pharmaceutical supply chain intermediaries and merger activity, and provides report The Commission shall submit to the appropriate committees of Congress a report that includes— the number and nature of complaints received by the Commission relating to an allegation of anticompetitive.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Researchers and scientific institutions affected by the bill
- Regulated entities and members of the public affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Educational institutions and students affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
Sponsors
Legislative Progress
IntroducedMr. Grassley (for himself, Ms. Cantwell, Mr. Blumenthal, Mr. Lankford, …
Mr. Grassley (for himself, Ms. Cantwell, Mr. Blumenthal, Mr. Lankford, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology